The latest analyst update trims Inogen’s fair value estimate from $13.00 to about $12.67 per share, a reduction of roughly 2.6%. Analysts are using this adjustment alongside the recent bullish ...

A month has gone by since the last earnings report for Inogen (INGN). Shares have added about 6.8% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent ...

Inogen (NASDAQ:INGN) reported first-quarter 2026 revenue of $85.1 million, up 3.4% year over year and “ahead of our ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (“POC”) space. The optimism, led by solid first-quarter 2025 ...

BEVERLY, Mass. - Inogen reported total revenue of $85.1 million for the first quarter of 2026, a 3.4% increase compared to the prior-year period, ahead of the company’s expectations.

It has been about a month since the last earnings report for Inogen (INGN). Shares have lost about 0.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

Q1 2026 Management view "Q1 came in at $85.1 million in total revenue, representing 3.4% year-over-year growth ahead of our expectations" (President, CEO & Director Kevin Smith). "International sales ...

Inogen, Inc. INGN incurred an adjusted loss per share of 30 cents for first-quarter 2026, wider than the year-ago period’s ...